Bangladeshi drug maker eyes Chinese market more with new generic products
DHAKA, July 23 (Xinhua) — A leading Bangladeshi pharmaceuticals company that immensely relies on Chinese API (Active Pharmaceutical Ingredient) has planned to further bolster its dominant position in the country’s demand for generic drugs specially. The Dhaka-based Beacon Pharmaceuticals Limited says the company is helping Chinese patients with 15 of its 16 products. Steps are […]
Read More
